Multimodality Treatment of Gynecomastia in Patients Receiving Antiandrogen Therapy for Prostate Cancer in the Era of Abiraterone Acetate and New Antiandrogen Molecules-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Multimodality Treatment of Gynecomastia in Patients Receiving Antiandrogen Therapy for Prostate Cancer in the Era of Abiraterone Acetate and New Antiandrogen Molecules

Published:2013 Issue:2 Volume:84 Page:92-99
ISSN:1423-0232
Container-title:Oncology
language:en
Short-container-title:Oncology

Author:

Alesini Daniele,Iacovelli Roberto,Palazzo Antonella,Altavilla Amelia,Risi Emanuela,Urbano Federica,Manai Chiara,Passaro Antonio,Magri Valentina,Cortesi Enrico

Publisher

S. Karger AG

Subject

Cancer Research,Oncology,General Medicine

Reference35 articles.

1. Variations in pattern of pubertal changes in girls.

2. INCIDENCE AND MANAGEMENT OF GYNECOMASTIA IN MEN TREATED FOR PROSTATE CANCER

3. Management of gynaecomastia in patients with prostate cancer: a systematic review

4. Gynecomastia in patients with prostate cancer: a review of treatment options

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. [11C]Choline PET/CT in a Patient with Prostate Cancer Biochemical Recurrence Showing Two Suspicious Findings in the Breast and Liver;Nuclear Medicine and Molecular Imaging;2023-07-27

2. Hormonal therapy;Medicines for Cancer;2023

3. Update of PSMA Theranostics in Prostate Cancer: Current Applications and Future Trends;Journal of Clinical Medicine;2022-05-12

4. Gynaecomastie en mastodynie als gevolg van androgeendeprivatietherapie bij prostaatkanker;Tijdschrift voor Urologie;2022-01

5. EAA clinical practice guidelines—gynecomastia evaluation and management;Andrology;2019-05-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP